Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001415889-25-000879

Options or other derivatives

  • Chief Accounting Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Burgess Julie Chief Accounting Officer 2025-01-02 Grant or award · Stock option (right to buy) +135,000 135,000 D: show line 1 in the form
Loading xslF345X05/form4-01062025_070130.xml…